By Jane Lindborg, Study Director & Research Scientist
RNA-based therapies have moved rapidly from theoretical promise to clinical reality. Today, mRNA, siRNA, antisense oligonucleotides (ASOs), and other RNA modalities are being explored across oncology, rare di...